Ms. Andrea Young reports

MEDMIRA PARTNERS WITH COLOMBIAN NATIONAL NAVY TO SCREEN PREGNANT WOMEN FOR SYPHILIS AND HIV AS PART OF EXPANSION IN LATIN AMERICA

MedMira Inc. and its Multiplo Rapid TP/HIV rapid test for syphilis and HIV have enabled the success of a humanitarian project led by the Colombian National Navy. Multiplo Rapid TP/HIV antibody test was used in a project to save the lives of unborn babies in remote areas of Colombia. This is just one example, among many of MedMira's expansion into Latin America and the company's growing customer base in this market. The company has recently earned several key product approvals, established new distribution agreements, and made shipments of its products built on its patented and versatile rapid vertical flow technology. This technology makes high-quality, cost-effective rapid testing solutions possible, in even the most remote locations.

As part of its continuing humanitarian efforts, the Colombian National Navy has implemented a new program called Expectant Family, which promotes the testing of sexually transmitted diseases in pregnant women living in remote areas where access to health care and laboratory testing is limited. The Colombian National Navy is using MedMira's Multiplo TP/HIV test to screen women at least twice during the pregnancy -- before the third month and prior to giving birth -- for syphilis and HIV.

"In the remote areas of Columbia, where health care services and laboratory testing is scarce, pregnant women do not have access to life-saving tests that could easily prevent mother-to-child transmission and neonatal deaths," said Dr. Liliana Lora Sierra, public health support professional, Colombian National Navy. "Working with MedMira, we are able to offer these women high-quality, rapid tests that will help prevent vertical transmission of TP/HIV that could not only save their lives but the lives of their unborn children. The test is very easy to perform and does not require any special training allowing us to screen patients at the point of care. Without MedMira's innovative technology, these women would not have access to tests that those living in urban areas benefit from."

In addition to the work in Columbia, MedMira has signed a distribution deal in Venezuela for the company's Reveal Rapid HIV antibody test. The deal is to provide tests to the private health care sector, which serves more than half of all patients, and last week, the company made the initial shipment to its partners in Venezuela. MedMira has also received approval to market the Reveal HIV test in Costa Rica and has registrations and evaluations for both Reveal and Multiplo product ranges under way in other Latin American countries, including Panama, Mexico, Ecuador, Brazil and Argentina. The company continues to leverage its partnership with the Pan American Health Organization having recently received new orders from the national HIV and TB program for the Ministry of Health in Belize.

The company has steadily increased its shipments to Latin America, over the last 12 months, due to the rising demand for cost-effective, fast and of high-quality products. In addition, the global need for tests that can simultaneously detect multiple markers has highlighted one of the key advantages of MedMira's patented vertical flow technology currency against its competitors, which is the ability to multiplex assays on one device. This enables MedMira to reach a much broader market by attracting partners and customers in the private health care, research and life sciences sectors.

We seek Safe Harbor.